Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24

Articles

Pages

637 items
12:13 PM, May 18, 2018  |  BC Week In Review | Financial News  |  Amended Offerings

Iterum sets IPO range

Antibiotics company Iterum Therapeutics plc (Dublin, Ireland) amended its proposed IPO on NASDAQ on May 16 and now plans to sell 5.3 million shares at $14-$16. At the $15 midpoint, the company would raise $80...
10:20 AM, Apr 13, 2018  |  BC Week In Review | Financial News  |  Amended Offerings

Morphosys amends NASDAQ listing

MorphoSys AG (Xetra:MOR; Pink:MPSYY) amended its proposed NASDAQ listing on April 9 and now plans to raise about $200 million through the sale of 8.3 million ADSs at $24.12 in a follow-on underwritten by Goldman...
8:25 AM, Feb 09, 2018  |  BC Week In Review | Financial News  |  Amended Offerings

Cesca amends $15M offering

Regenerative medicine company Cesca Therapeutics Inc. (NASDAQ:KOOL) added Maxim Group as its sole underwriter on Feb 5. to its proposed offering. The company continues to expect to raise up to $15 million but added an...
9:37 PM, Jan 18, 2018  |  BC Week In Review | Financial News  |  Amended Offerings

resTORbio amends IPO

resTORbio Inc. (Boston, Mass.) amended its proposed IPO on NASDAQ on Jan. 16 and now plans to sell 5.7 million shares at $14-$16. At the $15 midpoint, the company would raise $85 million and be...
9:37 PM, Jan 18, 2018  |  BC Week In Review | Financial News  |  Amended Offerings

Armo amends IPO

Immuno-oncology company Armo BioSciences Inc. (Redwood City, Calif.) amended its proposed IPO on NASDAQ on Jan. 16 and now plans to sell 6.7 million shares at $14-$16. At the $15 midpoint, the company would raise...
9:26 PM, Jan 18, 2018  |  BC Week In Review | Financial News  |  Amended Offerings

Dermatology company Menlo amends IPO

Dermatology company Menlo Therapeutics Inc. (Menlo Park, Calif.) amended its proposed IPO on NASDAQ on Jan. 12 and now plans to sell 5.7 million shares at $14-$16. At the $15 midpoint, the company would raise...
2:13 PM, Jan 05, 2018  |  BC Week In Review | Financial News  |  Amended Offerings

Axium proposes amended $5M IPO

Drug delivery company Axium Pharmaceuticals Inc. (High Point, N.C.) proposed to raise $5 million through the sale of 50 million shares at $0.10 per share in a self-underwritten IPO on Dec. 28, 2017. The proposal...
8:15 PM, Dec 07, 2017  |  BC Week In Review | Financial News  |  Amended Offerings

Cancer company Cue Biopharma updates IPO plans

Cancer company Cue Biopharma Inc. (Cambridge, Mass.) amended its proposed IPO on Dec. 5 and now plans to raise up to $60 million through the sale of up to 8 million shares at $7.50. A...
2:02 PM, Dec 01, 2017  |  BC Week In Review | Financial News  |  Amended Offerings

Neurology company Denali updates IPO plans

Neurology play Denali Therapeutics Inc. (South San Francisco, Calif.) amended its proposed IPO on Nov. 27 and now plans to sell 8.3 million shares at $17-$19. At $18, the company would raise $150 million and...
1:55 PM, Oct 03, 2017  |  BC Week In Review | Financial News  |  Amended Offerings

OptiNose amends IPO

On Oct. 3, OptiNose Inc. (Yardley, Pa.) amended its IPO on NASDAQ and now plans to sell 6.3 million shares at $15-$17. On Sept. 18, the company proposed to raise $100 million. Jefferies, Piper Jaffray,...

Pages